SUBSCRIBERS

Cordlife to buy cord blood bank HealthBaby

Published Wed, Jan 3, 2018 · 09:50 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Singapore

IN a bid to expand its presence in Hong Kong and Macau, Singapore-listed consumer healthcare company Cordlife Group has signed an agreement to buy out private cord blood bank HealthBaby Biotech (Hong Kong) Co from Stemgen Biotech Holding.

As part of the transaction, Cordlife will assume the debt of HK$138.2 million (S$23.8 million) which Stemgen Biotech Holding owed to HealthBaby Hong Kong.

Copyright SPH Media. All rights reserved.